In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

[Q]: Teacher and Nurse Support Act of 2002 - Amends the Higher Education Act of 1965 (HEA) to increase to a maximum of $17,500 the aggregate student loan obligation eligible for forgiveness or cancellation programs for teachers who serve full-time for five consecutive complete years in certain elementary or secondary schools (which qualify based on enrollment of disadvantaged students).Includes, under these HEA student loan forgiveness and cancellation programs, nurses who serve five consecutive complete years in a clinical setting or as a member of the nursing faculty at an accredited school of nursing.
[A]: A bill to amend the Higher Education act of 1965 to expand the loan forgiveness and loan cancellation programs for teachers, to provide loan forgiveness and loan cancellation programs for nurses, and for other purposes.

[Q]: Directs the Attorney General to establish a process for discretionary waiver of inadmissibility or deportation of specified aliens under similar circumstances as above.
Authorizes the supervised release of certain aliens from detention pending removal decisions. Subjects such decision (by the Attorney General) to administrative review only. Authorizes not more than three months' additional detention for inadmissible or criminal aliens deemed to be a risk in order to allow for removal negotiations between the United States and a foreign nation. Revises related release provisions.
[A]: Fairness for Permanent Residents Act of 1999

[Q]: Lower Prices Reduced with Increased Competition and Efficient Development of Drugs Act or the Lower PRICED Drugs Act - Amends the Federal Food, Drug, and Cosmetic Act to require an abbreviated application for a new drug containing certain antibiotics, the approved labeling for which includes a method of use that is claimed by a patent, to include a statement: (1) that identifies the relevant patent and the approved use covered by the patent; and (2) that the applicant is not seeking approval of such use.

Requires the court to consider the totality of circumstances and the public interest in deciding whether to shorten the 30-month period that delays the approval of an abbreviated drug application when a patent infringement case is filed against the applicant.

Limits market exclusivity provided for conducting pediatric studies of new drugs to only those new drugs for which the Secretary of Health and Human Services approves labeling that contains specific, therapeutically meaningful information about the use of the drug product in pediatric patients.

Prohibits the Secretary from delaying the approval of a new drug application while a petition is reviewed and considered. Requires the Secretary to take final agency action on a petition within six months of receipt, with no extensions allowed. Extends the 30-month period that the Secretary has to approve or disapprove an abbreviated application for a new drug by the amount of time that lapses from the date the Secretary receives a petition and the date of the final agency action on the petition, without regard to whether the Secretary grants or denies the petition.
[A]:
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to market exclusivity for certain drugs, and for other purposes.